Shenzhen Fushan Biotechnology Co., Ltd. was established in 2012. It is a national high-tech enterprise dedicated to the research and development and transformation of nutrition targeted intervention technology, and a special new small and medium-sized enterprise in Shenzhen. The company has a core R & D team led by 4 doctors. It is the founder and global leader of China's nutrition targeted design and manufacturing technology, leading and promoting the new trend of evidence-based medicine nutrition in China. Based on the theory of nutritional genomics, relying on the activation of Nrf2 for chronic disease nutrition intervention is a model of the company's nutritional targeted design technology application results. As a leading enterprise in the field of research and development, production and application of glucoraphanin, it has established a whole industrial chain from provenance screening, raw material extraction, product production to clinical application transformation, and has been identified as "glucoraphanin industry center" by the Food and Drug Homology working Committee of the Chinese Marketing Society ". In 2016, the company established the core theory of "nutrition targeted design technology" and "targeted food" concept, which has been cited by many influential professional books and seminars in the industry.
